Study
Molecular profiling of DLBCL patients treated in the HOVON84 trial
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001003949 | Other |
Study Description
Using a comprehensive NGS assay for simultaneous screening of mutations, copy number alterations, and translocations, 5 biology-based risk profiles could be reproduced in a Dutch DLBCL population and validated for outcome prediction. This approach will enable application as a diagnostic tool to select DLBCL patients for risk adapted treatment and help to develop biomarker-driven clinical trials for personalized medicine.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001008389 |
Shallow whole genome sequencing and targeted sequencing of DLBCL patients treated in the HOVON84 trial
|
Illumina HiSeq 4000 | 220 |
Who archives the data?
